NYSE CRTR Economy Event Watch the replay →

Advertisement
Advertisement

XHSvsGNOMETF Comparison

ETF 1
XHS

State Street SPDR S&P Health Care Services ETF

This fund is part of
US Health Care
-0%
VS
ETF 2
GNOM

Global X Genomics & Biotechnology ETF

This fund is part of
BioTech & Genomics
-0.39%

State Street SPDR S&P Health Care Services ETF (XHS) belongs to the US Health Care segment. Global X Genomics & Biotechnology ETF (GNOM) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. XHS is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.5% for GNOM. XHS is up 14.1% year-to-date (YTD) with +$13M in YTD flows. GNOM performs worse with 7.73% YTD performance, and +$4M in YTD flows. Run a side-by-side ETF comparison of XHS and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XHS vs GNOM performance and flow charts

Performance

-5.00.05.0%May 12May 19May 27Jun 3Jun 10

Cumulative Flows

0 M1 M2 M3 M4 MMay 12May 19May 27Jun 3Jun 10

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 06/12/2026
1M3MYTD1Y3Y5Y
Perf.
XHS
GNOM
+7.30%+4.86%
+18.28%+12.44%
+14.10%+7.73%
+25.29%+47.34%
+34.73%-2.60%
+7.94%-46.66%
Flows
XHS
GNOM
+$1M+$4M
+$8M+$6M
+$13M+$4M
+$79K-$4M
-$23M-$104M
-$74M+$8M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XHS
GNOM
+16.63%+31.23%
+17.99%+26.53%
+17.97%+28.94%
+21.22%+33.27%
Max drawdown
XHS
GNOM
-5.61%-7.88%
-11.97%-18.16%
-17.78%-46.21%
-32.53%-72.17%
Max drawdown duration
XHS
GNOM
21d36d
121d141d
362d1095d
1786d1807d
Trading data

Create an account to view trading data

Join for free
XHS
GNOM
Last sale
6/12/2026 at 1:30 PM
$122.08
$48.95
Previous close
06/11/2026
$121.70
$49.13
Consolidated volume
06/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of May 29, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XHS
GNOM
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 6/12/2026 at 1:30 PM
Live
Closed
XHS
GNOM
Last price
$122.08
$48.95
1D performance
+0.31%
-0.36%
AuM$109.72 M$59.59 M
E/R0.35%0.5%
Characteristics
XHS
GNOM
Management strategyPassivePassive
ProviderState Street Investment ManagementGlobal X
BenchmarkS&P Health Care Services Select Industry IndexSolactive Genomics Index
N° of holdings5145
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateSeptember 28, 2011April 5, 2019
ESGNoNo
Advertisement
Exposure

Countries

XHS
USA
99.91%
Other
0.09%
GNOM
USA
88%
Other
12%

Sectors

XHS
Health Care
86.95%
Other
13.05%
GNOM
Health Care
88.52%
Other
11.48%
Advertisement

Diversification

XHS

Total weight of top 15 holdings out of 15

33.75%
GNOM

Total weight of top 15 holdings out of 15

66.44%

Top 15 holdings

Data as of April 30, 2026
XHS
CENTENE
2.76%
HUMANA
2.55%
MOLINA HLTHCRE
2.44%
ELEVANCE HEALTH INC
2.39%
UNITEDHEALTH GRP
2.39%
ALIGNMENT HEALTHCARE
2.31%
CLOVER HEALTH INV CORP
2.28%
APOLLO MEDICAL HOLDINGS INC
2.25%
US10950A1060
2.14%
MEDNAX
2.10%
PRIVIA HEALTH GROUP
2.07%
CIGNA
2.05%
CVS HEALTH CORP
2.03%
CORVEL
2.00%
ACADIA HEALTHCARE COMPANY
2.00%
GNOM
MODERNA INC
7.59%
ARROWHEAD PHARMACEUTICALS INC
7.18%
US74006W2070
6.77%
ILLUMINA
5.19%
GUARDANT HEALTH INC
4.73%
BIOMARIN PHARMACEUTICAL
4.29%
VERTEX PHARMACEUTICALS
4.16%
NATERA
4.14%
BIONTECH SE ADR
4.03%
BIO-TECHNE CORP
3.44%
CRISPR THERAPEUTICS
3.32%
TWIST BIOSCIENCE CORP
3.14%
LEGEND BIOTECH
2.91%
NL0015002SN0
2.77%
BRISTOL-MYERS SQUIBB
2.77%
Frequently asked questions about XHS and GNOM

How have the XHS and GNOM ETFs performed in 2026?

As of June 12, 2026, XHS is up 14.1% year-to-date (YTD), while GNOM has returned 7.73%. That puts XHS better performer ahead so far this year.

Which ETF is attracting more investor money: XHS or GNOM?

Year-to-date, the XHS ETF saw +$13M in flows, compared to +$4M for GNOM.

Which ETF is more volatile: XHS or GNOM?

Over the past year, XHS had a volatility of 17.99%, while GNOM experienced 26.53%.

Which ETF is bigger: XHS or GNOM?

As of June 12, 2026, XHS holds $109.72 M in assets under management (AUM), while GNOM manages $59.59 M.

What sectors do the XHS and GNOM ETFs invest in?

XHS leans toward sectors like Health Care. Meanwhile, GNOM focuses on Health Care.

What are the top holdings of the XHS ETF and GNOM ETF?

XHS top holdings include CENTENE, HUMANA and MOLINA HLTHCRE. GNOM holds in its top three: MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070.

Which ETF is more diversified: XHS or GNOM?

XHS holds 58 securities with 33.75% of its assets in the top 15. GNOM has 49 securities and a top 15 weight of 66.44%.

Advertisement
Advertisement
Advertisement
ETF Comparison Tool

Have you tried our ETF Compare tool?

Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.